SEALSQ Aligns with COP29 Standards to Drive Sustainable Transformation in the IoT Industry
Geneva, Switzerland, Nov. 13, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a leader in the development […]
PREMIUM CATERING (HOLDINGS) LIMITED ANNOUNCES YEAR END FINANCIAL RESULTS
SINGAPORE, Nov. 13, 2024 (GLOBE NEWSWIRE) — Premium Catering (Holdings) Limited (“PC” or the “Company”) (Nasdaq: PC), a food caterer […]
Recursion and Exscientia Shareholders Approve the Proposed Combination
Salt Lake City USA, Oxford UK, Nov. 13, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) […]
Invizyne Technologies Begins Trading on NASDAQ
Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) — Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to […]
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
The World Health Organization (WHO) declared the spread of new Clade Ib Mpox a public health emergency of international concern […]
Sezzle Launches Flexible Financing at Rural King
Minneapolis, MN, Nov. 13, 2024 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // – Sezzle, a leader in […]
Color Star Technology Announces 100-for-1 Reverse Share Split
NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) — Color Star Technology Co., Ltd. (Nasdaq: ADD) (“Color Star” or the “Company”), […]
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the […]
Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering
Rutherford, NJ., Nov. 13, 2024 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, […]
INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer’s Disease
Boca Raton, Florida, Nov. 13, 2024 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology […]
